Takeda links with US medical groups for obesity drug research
This article was originally published in Scrip
In a signal of its increasing interest in the sector, Takeda has entered into a two-year collaboration with two medical institutions in the US to investigate and develop novel approaches to the treatment of obesity.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.